β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1
Author(s) -
Rowena Suriben,
Kelly A. Kaihara,
Magdalena Paolino,
Mike Reichelt,
Sarah Kummerfeld,
Zora Modrušan,
Debra L. Dugger,
Kim Newton,
Meredith Sagolla,
Joshua D. Webster,
Jinfeng Liu,
Matthias Hebrok,
Vishva M. Dixit
Publication year - 2015
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2015.10.076
Subject(s) - biology , ubiquitin ligase , secretion , insulin , microbiology and biotechnology , ubiquitin , endocrinology , medicine , gene , genetics
A variety of signals finely tune insulin secretion by pancreatic β cells to prevent both hyper-and hypoglycemic states. Here, we show that post-translational regulation of the transcription factors ETV1, ETV4, and ETV5 by the ubiquitin ligase COP1 (also called RFWD2) in β cells is critical for insulin secretion. Mice lacking COP1 in β cells developed diabetes due to insulin granule docking defects that were fully rescued by genetic deletion of Etv1, Etv4, and Etv5. Genes regulated by ETV1, ETV4, or ETV5 in the absence of mouse COP1 were enriched in human diabetes-associated genes, suggesting that they also influence human β-cell pathophysiology. In normal β cells, ETV4 was stabilized upon membrane depolarization and limited insulin secretion under hyperglycemic conditions. Collectively, our data reveal that ETVs negatively regulate insulin secretion for the maintenance of normoglycemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom